ARK Genomic Revolution ETF vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.71. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Vanguard Sht-Term Inflation-Protected Sec Idx ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | VTIP | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $44.55 | $50.75 |
52-Week Low | $24.02 | $49.39 |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTIP trades at $49.705, up 0.05% on the day, with a neutral technical signal overall. The ETF focuses on short-term inflation-protected securities, designed to hedge against rising costs. Recent news highlights institutional buying interest, with 55 North Private Wealth increasing its stake by 12.2% as of August 2026 (SEC filing).
The outlook for VTIP is supported by persistent inflation above the Fed's target, offering a potential hedge. Risks include interest rate uncertainty and competition from other bond ETFs. Analyst sentiment is cautiously positive, emphasizing its role in inflation-sensitive portfolios amid current economic conditions.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →